BioSpace News Archive

Tiziana Life Sciences Ltd. (Nasdaq: TLSA) announced that its Board of Directors has today authorized the Company’s management to implement a stock repurchase program for up to $5 million of the Company’s common shares at any time.

The global cancer imaging systems market is projected to be worth USD 12.24 Billion by 2027, according to a current analysis by Emergen Research.

The global healthcare Customer Relationship Management market is projected to reach value of USD 26.35 Billion by 2027, according to a current analysis by Emergen Research.

The global healthcare cloud computing market is estimated to reach USD 90.46 Billion by 2027, according to a current analysis by Emergen Research.

The Global mHealth Market is forecasted to be worth USD 361.67 Billion by 2027, according to a current analysis by Emergen Research.

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, announced the presentation of results from the INTRIGUE Phase 3 study of QINLOCK (ripretinib) in patients with gastrointestinal stromal tumor (GIST) previously treated with imatinib at the American Society of Clinical Oncology (ASCO) Plenary Series Session.

The first molecular electronics chip has been developed, realizing a 50-year-old goal of integrating single molecules into circuits to achieve the ultimate scaling limits of Moore’s Law.

The hormone refractory prostate cancer market may gain good growth during the forecast period of 2019-2029 on the back of the rising prevalence of this type of prostate cancer across the globe.

Fact.MR – A Market Research and Competitive Intelligence Provider: The inhalational anaesthesia drugs market is expected to increase at a high CAGR between 2016 and 2021, according to Fact.MR.

Artificial intelligence and machine learning tools have shown an incredible potential in expanding the reach of diabetes care.